You have 9 free searches left this month | for more free features.

abiraterone

Showing 26 - 50 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Newly Diagnosed Oligometastatic Prostate Cancer Trial in Long Beach, West Los Angeles, Richmond (procedure, radiation, drug)

Active, not recruiting
  • Newly Diagnosed Oligometastatic Prostate Cancer
  • radical prostatectomy
  • +4 more
  • Long Beach, California
  • +2 more
Mar 16, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +2 more
  • Abiraterone
  • +9 more
  • Atlanta, Georgia
  • +1 more
Feb 8, 2023

Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)

Completed
  • Prostate Cancer Metastatic
  • Metastasis
  • Alkmaar, Netherlands
  • +18 more
Apr 14, 2022

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Anchorage, Alaska
  • +163 more
Jan 18, 2023

Tumor Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer Trial in United States (XL102, Fulvestrant,

Recruiting
  • Neoplasm Malignant
  • +4 more
  • Atlanta, Georgia
  • +4 more
Apr 19, 2022

Prostate Gland Cancer, Which Spreads to Other Parts of Body, Who

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Radium-223 (Xofigo, BAY88-8223)
  • +2 more
  • Whippany, New Jersey
    US Flatiron prostate cancer database
Dec 8, 2021

Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)

Active, not recruiting
  • Metastatic Prostate Cancer
  • Chandler, Arizona
  • +183 more
Nov 24, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Birmingham, Alabama
  • +13 more
Jun 20, 2022

Solid Tumors Trial in Belgium, France, United States (INCB057643, Gemcitabine, Paclitaxel)

Terminated
  • Solid Tumors
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,

Active, not recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • Tucson, Arizona
  • +19 more
Oct 18, 2022

Prostate Cancer Trial in Worldwide (AMG 509, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • AMG 509
  • +2 more
  • Duarte, California
  • +18 more
Mar 17, 2022

Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)

Recruiting
  • Prostatic Neoplasms
  • +16 more
  • Birmingham, Alabama
  • +296 more
Jan 18, 2023

Prostate Cancer Trial in Honolulu (Denosumab, Enzalutamide, Abiraterone)

Terminated
  • Prostate Cancer
  • Denosumab
  • +3 more
  • Honolulu, Hawaii
    University of Hawaii Cancer Center
Nov 6, 2019

Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)

Completed
  • Prostate Cancer
  • Boston, Massachusetts
  • +91 more
Jan 18, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide ([Lu-177]-PNT2002, Abiraterone, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Tucson, Arizona
  • +47 more
Jun 1, 2022

Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)

Active, not recruiting
  • Prostatic Neoplasms
  • Androgen-deprivation Therapy (ADT)
  • +6 more
  • Akita, Japan
  • +76 more
Jan 19, 2023

Prostatic Tumors, Prostate Cancer, Tumor, Prostate Trial in Bethesda, Philadelphia (AMG 386, Abiraterone, Prednisone)

Completed
  • Prostatic Neoplasms
  • +3 more
  • AMG 386
  • +2 more
  • Bethesda, Maryland
  • +1 more
Feb 11, 2019

Prostate Cancer Trial in Boston (BKM120, Abiraterone, Prednisone)

Terminated
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Feb 1, 2019

Prostate Cancer Trial in Japan (Abiraterone, Prednisolone)

Completed
  • Prostate Cancer
  • Asahi, Japan
  • +18 more
Oct 19, 2017

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Mexico, United

Recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone
  • +14 more
  • Gilbert, Arizona
  • +301 more
Nov 8, 2021

Metastatic Castration-Resistant Prostatic Cancer Trial in Australia, Canada (cabazitaxel, Abiraterone, Enzalutamide 160mg daily

Unknown status
  • Metastatic Castration-Resistant Prostatic Cancer
  • Box Hill, Victoria, Australia
  • +14 more
Dec 4, 2017

Prostate Cancer Trial in New Brunswick (Abiraterone, ABT-263, Hydroxychloroquine)

Terminated
  • Prostate Cancer
  • Abiraterone
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Mar 30, 2017

Cancer Trial (Afuresertib, Enzalutamide, Abiraterone)

Withdrawn
  • Cancer
  • (no location specified)
Oct 5, 2016

Urokinase Plasminogen Activator Receptor in Abiraterone Treated

Terminated
  • Prostatic Neoplasms
  • Copenhagen, Denmark
    University Hospital of Copenhagen, Rigshospitalet
Nov 18, 2015